Published in Scand J Gastroenterol on July 01, 2011
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. Hum Vaccin Immunother (2015) 0.84
Clinical applications of bioactive milk components. Nutr Rev (2015) 0.83
Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection. J Infect Dis (2014) 0.77
Paediatric travel medicine: vaccines and medications. Br J Clin Pharmacol (2013) 0.75
Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans. PLoS Negl Trop Dis (2017) 0.75
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev (2005) 5.02
Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev (1997) 3.04
Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis (1990) 2.52
Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med (1988) 2.04
Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet (1989) 1.84
Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia. Emerg Infect Dis (2004) 1.74
Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS (1990) 1.46
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg (1992) 1.38
Travelers' diarrhea. Curr Opin Infect Dis (2010) 1.20
Immune components of bovine colostrum and milk. J Anim Sci (2008) 1.15
Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J (1998) 1.14
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun (2007) 1.07
Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) (2001) 1.04
In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br J Nutr (2000) 0.98
Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS. Arch Dis Child (1993) 0.98
Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal. J Infect Dis (1999) 0.91
Immunological activities associated with milk. Adv Nutr Res (2001) 0.91
Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr (1995) 0.88
Bovine colostrum as a biologic in clinical medicine: a review--Part II: clinical studies. Int J Clin Pharmacol Ther (2008) 0.86
Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin-producing E. Coli, and E. coli expressing intimin and hemolysin. J Pediatr Gastroenterol Nutr (1999) 0.86
A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis (2008) 0.85
Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (1999) 0.85
Evaluation of the buffering capacity of powdered cow's, goat's and soy milk and non-prescription antacids in the treatment of non-ulcer dyspepsia. S Afr Med J (2006) 0.80
Correlation between adherence to precautions issued by the WHO and diarrhea among long-term travelers to India. J Travel Med (2005) 0.80
Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. Acta Paediatr (1998) 0.78
Implementation of pretravel advice: good for malaria, bad for diarrhoea. Acta Clin Belg (2001) 0.77
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Probiotic use in clinical practice: what are the risks? Am J Clin Nutr (2006) 2.44
Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med (2002) 2.38
Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis (2006) 2.19
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect Immun (2002) 2.01
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun (2006) 2.01
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Characterization and evidence of mobilization of the LEE pathogenicity island of rabbit-specific strains of enteropathogenic Escherichia coli. Mol Microbiol (2002) 1.82
Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A (2002) 1.78
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med (2014) 1.60
Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun (2002) 1.54
Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol (2012) 1.41
Control of bacterial virulence by AraC-like regulators that respond to chemical signals. Trends Microbiol (2011) 1.32
Pathogenicity of Yersinia enterocolitica biotype 1A. FEMS Immunol Med Microbiol (2003) 1.32
Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells. Microb Pathog (2003) 1.26
Bicarbonate-mediated transcriptional activation of divergent operons by the virulence regulatory protein, RegA, from Citrobacter rodentium. Mol Microbiol (2008) 1.24
Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans. Clin Infect Dis (2003) 1.23
Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2004) 1.20
Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis (2009) 1.18
Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum. J Nat Prod (2003) 1.17
Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS One (2011) 1.13
Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol (2012) 1.12
RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium. Infect Immun (2008) 1.11
Characterisation of atypical enteropathogenic E. coli strains of clinical origin. BMC Microbiol (2009) 1.11
The H-NS protein represses transcription of the eltAB operon, which encodes heat-labile enterotoxin in enterotoxigenic Escherichia coli, by binding to regions downstream of the promoter. Microbiology (2005) 1.10
Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun (2007) 1.07
Enteric pathogens, intestinal permeability and nitric oxide production in acute gastroenteritis. Pediatr Infect Dis J (2002) 1.03
Transcriptional regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM cluster, encoding the type II secretion pathway in enterotoxigenic Escherichia coli. J Bacteriol (2006) 1.02
Homologues of insecticidal toxin complex genes in Yersinia enterocolitica biotype 1A and their contribution to virulence. Infect Immun (2005) 1.01
Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine (2013) 1.00
Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli. Infect Immun (2005) 1.00
The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect Immun (2012) 0.99
Fimbrial adhesins produced by atypical enteropathogenic Escherichia coli strains. Appl Environ Microbiol (2011) 0.99
Effects of inner ear trauma on the risk of pneumococcal meningitis. Arch Otolaryngol Head Neck Surg (2007) 0.98
A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol (2007) 0.98
Assembly of the type II secretion system such as found in Vibrio cholerae depends on the novel Pilotin AspS. PLoS Pathog (2013) 0.98
Pneumococcal meningitis threshold model: A potential tool to assess infectious risk of new or existing inner ear surgical interventions. Otol Neurotol (2006) 0.98
Bicarbonate-mediated stimulation of RegA, the global virulence regulator from Citrobacter rodentium. J Mol Biol (2009) 0.97
The relentless evolution of pathogenic Escherichia coli. Clin Infect Dis (2005) 0.97
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol (2008) 0.97
Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol (2011) 0.96
Virulence regulation in Citrobacter rodentium: the art of timing. Microb Biotechnol (2009) 0.96
Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry. J Clin Microbiol (2011) 0.96
Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium. Infect Immun (2009) 0.95
Pneumococcal meningitis: development of a new animal model. Otol Neurotol (2006) 0.94
Transcriptional analysis of the grlRA virulence operon from Citrobacter rodentium. J Bacteriol (2010) 0.93
Enzyme therapy for management of coeliac disease. Scand J Gastroenterol (2005) 0.93
Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D. J Clin Microbiol (2010) 0.92
Reactive oxygen species are the major antibacterials against Salmonella Typhimurium purine auxotrophs in the phagosome of RAW 264.7 cells. Cell Microbiol (2007) 0.90
Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog (2012) 0.89
Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein. PLoS One (2013) 0.88
Detection of enterohaemorrhagic Escherichia coli in patients attending hospital in Melbourne, Australia. Pathology (2004) 0.88
Assessment of the protective effect of pneumococcal vaccination in preventing meningitis after cochlear implantation. Arch Otolaryngol Head Neck Surg (2007) 0.87
Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis. Otolaryngol Head Neck Surg (2007) 0.87
Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol (2011) 0.86
Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res Notes (2013) 0.84
Restriction of DNA encoding selectable markers decreases the transformation efficiency of Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 0.84
Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis (2008) 0.84
Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis. Infect Immun (2014) 0.82
A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli. Vaccine (2012) 0.81
Involvement of PatE, a prophage-encoded AraC-like regulator, in the transcriptional activation of acid resistance pathways of enterohemorrhagic Escherichia coli strain EDL933. Appl Environ Microbiol (2012) 0.81
A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building. J Biol Chem (2011) 0.81
RegR virulence regulon of rabbit-specific enteropathogenic Escherichia coli strain E22. Infect Immun (2013) 0.81
Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun (2009) 0.81
Disarming bacterial virulence through chemical inhibition of the DNA binding domain of an AraC-like transcriptional activator protein. J Biol Chem (2013) 0.81
Genome-wide analysis of the Pho regulon in a pstCA mutant of Citrobacter rodentium. PLoS One (2012) 0.80
Contribution of a novel gene, rpeA, encoding a putative autotransporter adhesin to intestinal colonization by rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2007) 0.80
Pneumococcal meningitis post-cochlear implantation: potential routes of infection and pathophysiology. Otolaryngol Head Neck Surg (2010) 0.79
Autogenous transcriptional regulation of the regA gene, encoding an AraC-Like, essential virulence regulator in Citrobacter rodentium. J Bacteriol (2011) 0.79
Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun (2013) 0.77
Control of bacterial virulence by the RalR regulator of the rabbit-specific enteropathogenic Escherichia coli strain E22. Infect Immun (2013) 0.76
Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications. J Pharm Sci (2008) 0.76
Meningitis after cochlear implantation. BMJ (2007) 0.75
Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation. Laryngoscope (2006) 0.75
Rabbit-specific fimbriae, Ral, alter the patterns of in vitro adherence and intestinal colonisation of rabbits by human-specific enteropathogenic E. coli. Microbes Infect (2009) 0.75
Yersinia enterocolitica biotype 1A: not as harmless as you think. Adv Exp Med Biol (2003) 0.75
Pneumococcal meningitis post-cochlear implantation: preventative measures. Otolaryngol Head Neck Surg (2010) 0.75